Unbiased AI-powered news
4 stories related to this topic, newest first.
news.google.comThe University of Oxford started trials of a vaccine against the Bundibugyo strain of Ebola on July 15. The move comes as the virus spreads in the Democratic Republic of Congo and Uganda, with nearly 2,000 infections reported since mid-May.
SemaforThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.
montrealgazette.comAn FDA vaccine advisory committee voted unanimously to recommend Moderna's mRNA-based flu vaccine for adults 50 and older. The vaccine showed 27 percent greater effectiveness than standard shots in late-stage trials.
EuronewsA Phase 1 safety study of an AI-designed protein vaccine against multiple coronaviruses enrolled 39 volunteers and reported no significant safety issues. A Phase 2 trial is now planned.